Dingwei Ye
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
-
- Ferroptosis and cancer prognosis
- Renal cell carcinoma treatment
- Prostate Cancer Treatment and Research
Papers in
-
- Renal cell carcinoma treatment 22
- Ferroptosis and cancer prognosis 21
- Prostate Cancer Treatment and Research 9
-
- Epigenetics and DNA Methylation 11
- Renal and related cancers 9
- Co-authors
- Hailiang Zhang (43 shared papers)Yao Zhu (28 shared papers)Guohai Shi (45 shared papers)Yuanyuan Qu (40 shared papers)Fangning Wan (28 shared papers)Wenhao Xu (45 shared papers)Yiping Zhu (25 shared papers)Bo Dai (11 shared papers)
- Journals
- Frontiers in Oncology (8 papers)Scientific Reports (5 papers)World Journal of Surgical Oncology (5 papers)Oncotarget (4 papers)Asian Journal of Andrology (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Dingwei Ye
110 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 100
- Cancer Research 713
- Pulmonary and Respiratory Medicine 846
- Oncology 374
- Molecular Biology 923
- Immunology 169
Countries citing papers authored by Dingwei Ye
This map shows the geographic impact of Dingwei Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dingwei Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dingwei Ye more than expected).
Fields of papers citing papers by Dingwei Ye
This network shows the impact of papers produced by Dingwei Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dingwei Ye. The network helps show where Dingwei Ye may publish in the future.
Co-authors
The 25 scholars most cited alongside Dingwei Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 184 | |
| 2 | 2021 | 135 | |
| 3 | 2014 | 84 | |
| 4 | 2020 | 67 | |
| 5 | 2023 | 62 | |
| 6 | 2016 | 60 | |
| 7 | 2022 | 59 | |
| 8 | 2023 | 58 | |
| 9 | 2020 | 52 | |
| 10 | 2014 | 47 | |
| 11 | 2022 | 47 | |
| 12 | 2014 | 46 | |
| 13 | 2024 | 45 | |
| 14 | 2016 | 45 | |
| 15 | 2022 | 40 | |
| 16 | 2020 | 40 | |
| 17 | 2014 | 40 | |
| 18 | 2020 | 37 | |
| 19 | 2016 | 35 | |
| 20 | 2015 | 35 |
About Dingwei Ye
Dingwei Ye is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Surgery and Oncology, having authored 115 papers that have together received 2.4k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (22 papers), Ferroptosis and cancer prognosis (21 papers), Cancer, Lipids, and Metabolism (18 papers), Bladder and Urothelial Cancer Treatments (14 papers), Epigenetics and DNA Methylation (11 papers), Cancer-related molecular mechanisms research (10 papers), Renal and related cancers (9 papers) and Prostate Cancer Treatment and Research (9 papers). The work is most often cited by research in Cancer Research (713 citations), Pulmonary and Respiratory Medicine (846 citations), Oncology (374 citations), Molecular Biology (923 citations) and Immunology (169 citations). Dingwei Ye has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hailiang Zhang, Yao Zhu, Guohai Shi, Yuanyuan Qu, Fangning Wan, Wenhao Xu, Yiping Zhu, Bo Dai, Xi Tian and Aihetaimujiang Anwaier. Their work appears in journals such as Frontiers in Oncology, Scientific Reports, World Journal of Surgical Oncology, Oncotarget and Asian Journal of Andrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.